Patents Assigned to Merck Patents GmbH
  • Patent number: 9594260
    Abstract: This invention relates to colored particles comprising core particles and a polymeric shell, a process for their preparation, electrophoretic fluids comprising such particles, and electrophoretic display devices comprising such fluids.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: March 14, 2017
    Assignee: Merck Patent GmbH
    Inventors: Louise Diane Farrand, Emily Jane Thomas, Jonathan Henry Wilson
  • Patent number: 9593279
    Abstract: The present invention relates to liquid-crystalline media comprising one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters R1-R3, Z21, Z31, Z32 and rings A11, A12, A13, A21, A22, A31, and A32 are as defined herein, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: March 14, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Michael Wittek, Dagmar Klass, Atsutaka Manabe, Christian Jasper, Volker Reiffenrath, Constanze Brocke, Detlef Pauluth
  • Publication number: 20170069915
    Abstract: The present invention relates to stable catalyst ink formulations comprising am electrospinning polymer selected from halogen-comprising polymers. The present invention further relates to electrospinning of such ink formulation, to the so-obtained electrospun fibrous mat as well as to articles comprising such electrospun fibrous mat.
    Type: Application
    Filed: January 19, 2015
    Publication date: March 9, 2017
    Applicant: Merck Patent GmbH
    Inventors: Onur KAS, Ashley MOORE, Ryan SYLVIA, Gabriel TKACIK
  • Patent number: 9588357
    Abstract: This invention relates to particles comprising a pigment core particle encapsulated by a polymer, a process for their preparation, electrophoretic fluids comprising such particles, and electrophoretic display devices comprising such fluids.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: March 7, 2017
    Assignee: Merck Patent GmbH
    Inventors: Lewis Blackman, Louise Diane Farrand, Jonathan Henry Wilson, Simon Biggs, Olivier Cayre, Simon Lawson, Alexandre Richez
  • Patent number: 9586938
    Abstract: The invention provides novel cyclic amine azaheterocyclic carboxamide according to Formula (I), Formula (II) and Formula (III) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: March 7, 2017
    Assignee: Merck Patent GmbH
    Inventors: Bayard R. Huck, Xiaoling Chen, Constantin Neagu, Reinaldo Jones, Yufang Xiao, Igor Mochalkin
  • Patent number: 9585891
    Abstract: The present invention relates to alpha hydroxy amides including compounds of formula I: and related compounds and their use in the prophylaxis and treatment of inflammatory disorders and diseases, wherein T1, T2, W and RW have the meanings given in claim 1.
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: March 7, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Mathilde Muzerelle, Dominique Swinnen, Jeyaprakashnarayanan Seenisamy
  • Patent number: 9590178
    Abstract: The invention relates to novel polymers containing one or more 4,8-dioxycarbonylalkyl-benzo[1,2-b:4,5-b?]dithiophene repeating units or their thioester derivatives, methods for their preparation and monomers used therein, blends, mixtures and formulations containing them, the use of the polymers, blends, mixtures and formulations as semiconductor in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers, blends, mixtures or formulations.
    Type: Grant
    Filed: August 29, 2012
    Date of Patent: March 7, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: William Mitchell, Nicolas Blouin, Amy Phillips, Steven Tierney, Miguel Carrasco-Orozco, Toby Cull
  • Publication number: 20170056474
    Abstract: The present invention provides a new dosing regimen for administration of FGF18 in the treatment of a cartilage disorder, such as osteoarthritis or cartilage injury. Specifically provided is a preferred treatment scheme comprising administrations every 2 weeks of an FGF-18 compound per treatment cycle. The new dosing regimen can include the co-administration of an anti-inflammatory drug.
    Type: Application
    Filed: February 20, 2015
    Publication date: March 2, 2017
    Applicant: MERCK PATENT GMBH
    Inventors: CHRISTOPH H. LADEL, HANS GUEHRING
  • Publication number: 20170062722
    Abstract: The present invention relates to a methoxyaryl surface modifier. In addition the present invention also relates to organic electronic devices comprising such methoxyaryl surface modifier.
    Type: Application
    Filed: February 16, 2015
    Publication date: March 2, 2017
    Applicants: Merck Patent GmbH, InnovationLab GmbH, Technische Universitaet Braunschweig, Max-Planck-Gesellschaft Zur Foerderung Der Wissens chaften E.V.
    Inventors: Malte JESPER, Manuel HAMBURGER, Janusz SCHINKE, Milan ALT, Klaus MUELLEN
  • Publication number: 20170062744
    Abstract: The present invention relates to a cyclic amine surface modifier. In addition the present invention also relates to organic electronic devices comprising such cyclic amine surface modifier.
    Type: Application
    Filed: February 16, 2015
    Publication date: March 2, 2017
    Applicants: MERCK PATENT GMBH, INNOVATIONLAB GMBH, TECHNISCHE UNIVERSITAET BRAUNSCHWEIG, MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENS CHAFTEN E.V.
    Inventors: Malte JESPER, Manuel HAMBURGER, Janusz SCHINKE, Milan ALT, Klaus MUELLEN
  • Publication number: 20170062736
    Abstract: The application relates to compounds having functional substituents in a specific spatial arrangement, to devices comprising same, and to the preparation and use thereof.
    Type: Application
    Filed: March 30, 2015
    Publication date: March 2, 2017
    Applicant: Merck Patent GmbH
    Inventors: AMIR HOSSAIN PARHAM, Tobias GROSSMANN, Anja JATSCH, Thomas EBERLE, Jonas Valentin KROEBER, Christof PFLUMM, Lars DOBELMANN
  • Patent number: 9580449
    Abstract: The present invention provides novel pyrimidine and pyridine compounds according to Formula (I), Formula (II), Formula (III), Formula (IV) and Formula (V) their manufacture and use for the treatment of hyperproliferative diseases including, but not limited to, cancer, lupus, allergic disorders, Sjogren's disease and rheumatoid arthritis. In preferred embodiments, the present invention describes irreversible kinase inhibitors including, but not limited to, inhibitors of Bruton's tyrosine kinase.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: February 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Brian L. Hodous, Lesley Liu-Bujalski, Reinaldo Jones, Donald Bankston, Theresa L. Johnson, Igor Mochalkin, Ngan Nguyen, Hui Qiu, Andreas Goutopoulos, Nadia Brugger
  • Patent number: 9583713
    Abstract: Embodiments in accordance with the present invention provide for the use of polycycloolefins in electronic devices and more specifically to the use of such polycycloolefins as interlayers applied to fluoropolymer layers used in the fabrication of electronic devices, the electronic devices that encompass such polycycloolefin interlayers and processes for preparing such polycycloolefin interlayers and electronic devices.
    Type: Grant
    Filed: September 1, 2011
    Date of Patent: February 28, 2017
    Assignees: Merck Patent GmbH, Promerus LLC
    Inventors: David Christoph Mueller, Pawel Miskiewicz, Toby Cull, Piotr Wierzchowiec, Andrew Bell, Edmund Elce, Larry F. Rhodes, Kazuyoshi Fujita, Hendra Ng, Pramod Kandanarachchi, Steven Smith
  • Patent number: 9580610
    Abstract: The present invention relates to aluminium oxide pastes and to a process for the use of the aluminium oxide pastes for the formation of Al2O3 coatings or mixed Al2O3 hybrid layers.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: February 28, 2017
    Assignee: MERCK PATENT GMBH
    Inventors: Ingo Koehler, Oliver Doll, Werner Stockum, Sebastian Barth
  • Patent number: 9580649
    Abstract: The present invention relates to a process for the preparation of a europium-doped alkaline-earth metal siliconitride or silicooxynitride having increased emission efficiency. The present invention furthermore relates to europium-doped alkaline-earth metal siliconitrides or silicooxynitrides which are obtainable by the preparation process according to the invention, and to the use of the europium-doped alkaline-earth metal siliconitrides or silicooxynitrides according to the invention as conversion phosphors. The present invention furthermore also relates to a light-emitting device which comprises a europium-doped alkaline-earth metal siliconitride or silicooxynitride according to the invention.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: February 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Tim Vosgroene, Holger Winkler, Ralf Petry, Andreas Benker, Christof Hampel
  • Patent number: 9583717
    Abstract: The present invention relates to crosslinkable compounds, to the crosslinked compounds obtained from these compounds, and to processes for the preparation thereof. The invention is furthermore directed to the use of these compounds in electronic devices and to the corresponding electronic devices themselves.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: February 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Aurélie Ludemann, Alice Julliart, Anna Hayer, Anja Gerhard, Dominik Joosten, Holger Heil, Fabrice Eckes
  • Patent number: 9580443
    Abstract: The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: February 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Ruoxi Lan, Bayard R. Huck, Xiaoling Chen, Yufang Xiao
  • Patent number: 9580653
    Abstract: The invention relates to the compounds of the formula I and to a liquid-crystalline medium based on a mixture of polar compounds which contains at least one compound of the formula I in which R1, L1, L2 and L3 and m have the meanings indicated in claim 1 and to the use of the LC mixtures for an active-matrix display, in particular based on the VA, PSA and PS-VA effect.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: February 28, 2017
    Assignee: Merck Patent GmbH
    Inventors: Graziano Archetti, Andreas Taugerbeck, Izumi Saito
  • Publication number: 20170051201
    Abstract: The present invention relates to compounds of the formula I, (A2-2nBn)x(Ge1-mMm)yO(x+2y):Mn4+??I in which the parameters A, B, M, m, n, x, and y have one of the meanings according to claim 1. Furthermore, the invention relates to a process for the preparation of the compounds of the formula I, to the use of these compounds as conversion phosphors, and to an emission-converting material comprising at least one compound of the formula I. The present invention furthermore relates to a light-emitting device which comprises at least one compound of the formula I according to the invention.
    Type: Application
    Filed: April 1, 2015
    Publication date: February 23, 2017
    Applicant: Merck Patent GmbH
    Inventors: Ralf PETRY, Holger WINKLER, Thomas JUESTEL, Florian BAUR, Kira HEERDT
  • Publication number: 20170051337
    Abstract: The present invention relates to a method of detecting a microorganism, in particular Staphylococcus aureus, in a sample, comprising the steps of a) incubating the sample with a slow off-rate modified aptamer (SOMAmer) comprising a fluorescent label, b) optionally washing the sample, c) analyzing the sample by a fluorescence-based detection method. The invention further relates to a slow off-rate modified aptamer comprising a fluorescent label, wherein the SOMAmer comprises a nucleotide sequence specific for Staphylococcus aureus, its use for detecting Staphylococcus aureus cells in a sample, and to a microarray or biosensor and a kit comprising at least one of such SOMAmers comprising a fluorescent label.
    Type: Application
    Filed: February 20, 2015
    Publication date: February 23, 2017
    Applicants: Merck Patent GmbH, SOMALOGIC, Inc.
    Inventors: Anne BAUMSTUMMLER, Frederic MARC-KREUCHER, David LEHMANN, Urs OCHSNER, Nebojsa JANJIC